MC

613.1

-1%↓

ALV

279.5

-1.65%↓

SAF

192.05

-0.23%↓

BBVA

8.918

-2.02%↓

BN

65.02

+0.99%↑

MC

613.1

-1%↓

ALV

279.5

-1.65%↓

SAF

192.05

-0.23%↓

BBVA

8.918

-2.02%↓

BN

65.02

+0.99%↑

MC

613.1

-1%↓

ALV

279.5

-1.65%↓

SAF

192.05

-0.23%↓

BBVA

8.918

-2.02%↓

BN

65.02

+0.99%↑

MC

613.1

-1%↓

ALV

279.5

-1.65%↓

SAF

192.05

-0.23%↓

BBVA

8.918

-2.02%↓

BN

65.02

+0.99%↑

MC

613.1

-1%↓

ALV

279.5

-1.65%↓

SAF

192.05

-0.23%↓

BBVA

8.918

-2.02%↓

BN

65.02

+0.99%↑

Search

Bayer AG

Closed

Sector Finance

28.935 -0.57

Overview

Share price change

24h

Current

Min

28.91

Max

29.185

Key metrics

By Trading Economics

Income

-2B

-34M

Sales

-2.6B

11B

P/E

Sector Avg

30.9

19.92

EPS

0.94

Profit margin

-0.305

EBITDA

-2.6B

1.7B

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+3.52 upside

Market Stats

By TradingEconomics

Market Cap

182M

28B

Previous open

29.51

Previous close

28.935

News Sentiment

By Acuity

43%

57%

103 / 458 Ranking in Finance

Technical Score

By Trading Central

Confidence

Very Strong Bullish Evidence

Bayer AG Chart

Related News

16 sie 2024, 08:28 UTC

Major Market Movers

Bayer Shares Surge After Appeal Win in Roundup Cancer Suit

15 sie 2024, 21:43 UTC

Earnings

Bayer's Monsanto Wins Appeal in Roundup Cancer Suit

6 sie 2024, 10:56 UTC

Earnings

Bayer Posts Net Loss as Tough Agriculture Market Bites -- Update

6 sie 2024, 09:00 UTC

Earnings

Correction to Bayer Article

6 sie 2024, 06:29 UTC

Earnings

Bayer Posts Net Loss, Dragged by Weaker Crop-Science Performance

14 maj 2024, 13:21 UTC

Earnings

Bayer Plans More Job Cuts in Push for Fewer Bosses -- Update

14 maj 2024, 06:13 UTC

Earnings

Bayer Net Profit Falls on Lower Sales, Currency Headwinds

23 sie 2024, 08:51 UTC

Market Talk

BMW's EV Coup Over Tesla in Europe Shows Strength as Tesla Products Age -- Market Talk

16 sie 2024, 14:21 UTC

Market Talk

Bayer's Appeal Win Could Be First Step to End Roundup Litigation -- Market Talk

16 sie 2024, 08:58 UTC

Earnings
Hot Stocks

Stocks to Watch Friday: Applied Materials, H&R Block, Bayer, Bavarian Nordic -- WSJ

6 sie 2024, 10:47 UTC

Market Talk

Bayer Could Face Consensus Earnings Downgrades Amid Currency Headwinds -- Market Talk

6 sie 2024, 08:55 UTC

Market Talk
Earnings

Bayer's 2Q Beat Boosted By Pharma Business -- Market Talk

6 sie 2024, 08:20 UTC

Market Talk
Earnings

Bayer's 2Q Results Are a Mixed Bag -- Market Talk

6 sie 2024, 06:57 UTC

Market Talk
Earnings

Bayer 2Q Results Could Lead to Muted Share Price Response -- Market Talk

6 sie 2024, 05:34 UTC

Earnings

Bayer Saw 2024 Core EPS Between EUR5.10 and EUR5.50

6 sie 2024, 05:34 UTC

Earnings

Bayer Saw 2024 Ebitda Before Special Between EUR10.7B and EUR11.3B

6 sie 2024, 05:33 UTC

Earnings

Bayer Backs 2024 View

6 sie 2024, 05:33 UTC

Earnings

Analysts Saw Bayer 2Q Ebitda Before Special Items at EUR2.08B

6 sie 2024, 05:33 UTC

Earnings

Bayer 2Q Ebitda Before Special Items EUR2.11B

6 sie 2024, 05:32 UTC

Earnings

Analysts Saw Bayer 2Q Net Pft at EUR70M

6 sie 2024, 05:32 UTC

Earnings

Bayer 2Q Net Loss EUR34M

6 sie 2024, 05:31 UTC

Earnings

Analysts Saw Bayer 2Q Core EPS at EUR0.84

6 sie 2024, 05:31 UTC

Earnings

Bayer 2Q Core EPS EUR0.94

6 sie 2024, 05:31 UTC

Earnings

Bayer 2Q EBIT EUR525M

6 sie 2024, 05:30 UTC

Earnings

Analysts Saw Bayer 2Q Rev at EUR10.82B

6 sie 2024, 05:30 UTC

Earnings

Bayer 2Q Rev EUR11.14B

12 lip 2024, 07:05 UTC

Market Talk

Bayer's Cost-Savings and Cash Delivery Key Focus for 2Q -- Market Talk

5 cze 2024, 09:57 UTC

Hot Stocks

Stocks to Watch Wednesday: CrowdStrike, HPE, Dollar Tree -- WSJ

14 maj 2024, 11:00 UTC

Market Talk
Earnings

Bayer Earnings Show Progression on Turnaround Strategy -- Market Talk

14 maj 2024, 05:34 UTC

Earnings

Bayer Backs 2024 Currency-Adjusted Outlook

Peer Comparison

Price change

Bayer AG Forecast

Price Target

By TipRanks

3.52% upside

12 Months Forecast

Average 30 EUR  3.52%

High 34 EUR

Low 26 EUR

Based on 10 Wall Street analysts offering 12 month price targets forBayer AG - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

10 ratings

1

Buy

9

Hold

0

Sell

Technical Score

By Trading Central

27.69 / 28.975Support & Resistance

Short Term

Very Strong Bullish Evidence

Intermediate Term

Very Strong Bullish Evidence

Long Term

Bullish Evidence

Sentiment

By Acuity

103 / 458 Ranking in Finance

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

EBITDA

Operating profit

$

About Bayer AG

Bayer AG is a German-based life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The company is focusing on their oncology platform o Targeted Alpha Therapies for treating prostate cancer. Th Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and non